Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.23750/abm.v91i4.10941 http://scihub22266oqcxt.onion/10.23750/abm.v91i4.10941 33525235!7927548!33525235     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Biomed 2020 ; 91 (4): e2020196 Nephropedia Template TP {{tp|p=33525235|t=2020. Obstructive sleep apnea, cpap and COVID-19: a brief review |pdf=|usr=}}{{33525235}} gab.com Text Obstructive sleep apnea, cpap and COVID-19: a brief review JO: Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=33525235 #FOAvip Obstructive sleep apnea (OSA) is a broadly diffused curable chronic low-grade inflammatory disease sharing impressive clinical and pathogenetic features with Covid-19. Moreover, a potential role of OSA as a detrimental factor for Covid-19 severity has been hypothesized. Continuous positive airway pressure (CPAP) is the mainstay treatment for moderate-severe OSA, but the beneficial effects of ventilation strongly depend on medical expertise and on the patient's adherence and compliance. Although several papers have analyzed the overlaps and outcomes of OSA and Covid-19, limited attention has been dedicated to ventilatory adherence and management of OSA cohorts exposed to Covid-19. We briefly review the literature data, pointing out the main risks and benefits of CPAP for OSA patients in the pandemic setting. Twit Text FOAVip Obstructive sleep apnea, cpap and COVID-19: a brief review ????Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=33525235 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33525235 #FOAvip English Wikipedia <ref>{{Cite pmid|33525235}}</ref> Obstructive sleep apnea, cpap and COVID-19: a brief review #MMPMID33525235 Mutti C; Azzi N; Soglia M; Pollara I; Alessandrini F; Parrino L Acta Biomed 2020[Nov]; 91 (4): e2020196 PMID33525235show ga Obstructive sleep apnea (OSA) is a broadly diffused curable chronic low-grade inflammatory disease sharing impressive clinical and pathogenetic features with Covid-19. Moreover, a potential role of OSA as a detrimental factor for Covid-19 severity has been hypothesized. Continuous positive airway pressure (CPAP) is the mainstay treatment for moderate-severe OSA, but the beneficial effects of ventilation strongly depend on medical expertise and on the patient's adherence and compliance. Although several papers have analyzed the overlaps and outcomes of OSA and Covid-19, limited attention has been dedicated to ventilatory adherence and management of OSA cohorts exposed to Covid-19. We briefly review the literature data, pointing out the main risks and benefits of CPAP for OSA patients in the pandemic setting. |*Continuous Positive Airway Pressure[MESH] |COVID-19/complications/*therapy[MESH] |Humans[MESH] |Patient Compliance[MESH]Obstructive sleep apnea, cpap and COVID-19: a brief review (epmc).pdf DeepDyve Pubget Overpricing